Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.

Inclusion Criteria: * The study population consisted of allergic participants indicated for treatment with hymenoptera venom immunotherapy (Apis mellifera or Vespula spp.) according to standard clinical practice. * Participants of both sexes aged 14 years or more. * Participants who have not received immunotherapy with hymenoptera venom in the previous 5 years. * Participants who have agreed to take part in the study and sign the informed consent form. In the case of minors, the patient's parent or guardian must also sign. Exclusion Criteria: * Pregnant or breastfeeding women. * Having received immunotherapy with hymenoptera venom during the 5 years prior to the start of the study. * Participants who do not agree to participate and/or do not sign the informed consent form. * Participants who do not comply with medical indications or do not cooperate with immunotherapy treatment.